Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck
Condition:   Adenoid Cystic Carcinoma of the Head and Neck Interventions:   Drug: OBT076;   Drug: Balstilimab Sponsor:   Groupe Oncologie Radiotherapie Tete et Cou Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2023 Category: Research Source Type: clinical trials